54 related articles for article (PubMed ID: 30040982)
1. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
[TBL] [Abstract][Full Text] [Related]
2. ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
Horibata S; Rice EJ; Mukai C; Marks BA; Sams K; Zheng H; Anguish LJ; Coonrod SA; Danko CG
PLoS One; 2018; 13(4):e0194023. PubMed ID: 29608602
[TBL] [Abstract][Full Text] [Related]
3. Expression Analysis of GDNF/RET Signaling Pathway in Human AD-MSCs Grown in HEK 293 Conditioned Medium (HEK293-CM).
Esmaeilizadeh Z; Mohammadi B; Rajabibazl M; Ghaderian SMH; Omrani MD; Fazeli Z
Cell Biochem Biophys; 2020 Dec; 78(4):531-539. PubMed ID: 32803668
[TBL] [Abstract][Full Text] [Related]
4. RET protein promotes non-adherent growth of NB-39-nu neuroblastoma cell line.
Futami H; Sakai R
Cancer Sci; 2009 Jun; 100(6):1034-9. PubMed ID: 19320641
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.
Griseri P; Garrone O; Lo Sardo A; Monteverde M; Rusmini M; Tonissi F; Merlano M; Bruzzi P; Lo Nigro C; Ceccherini I
Oncotarget; 2016 May; 7(18):26465-79. PubMed ID: 27034161
[TBL] [Abstract][Full Text] [Related]
6. RET signaling in breast cancer therapeutic resistance and metastasis.
Pecar G; Liu S; Hooda J; Atkinson JM; Oesterreich S; Lee AV
Breast Cancer Res; 2023 Mar; 25(1):26. PubMed ID: 36918928
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Acute and Chronic Methamphetamine Treatment in Mice on Gdnf System Expression Reveals a Potential Mechanism of Schizophrenia Susceptibility.
Casserly L; Garton DR; Montaño-Rodriguez A; Andressoo JO
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759827
[TBL] [Abstract][Full Text] [Related]
8. ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R; Geh D; Nelson R; Ramon-Gil E; Wilson L; Schmidt EN; Walker L; Adamson B; Buskin A; Hepburn AC; Hodgson K; Kendall H; Frame FM; Maitland N; Coffey K; Strand DW; Robson CN; Elliott DJ; Heer R; Macauley M; Munkley J; Gaughan L; Leslie J; Scott E
Commun Biol; 2024 Mar; 7(1):276. PubMed ID: 38448753
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.
Bosco EE; Christie RJ; Carrasco R; Sabol D; Zha J; DaCosta K; Brown L; Kennedy M; Meekin J; Phipps S; Ayriss J; Du Q; Bezabeh B; Chowdhury P; Breen S; Chen C; Reed M; Hinrichs M; Zhong H; Xiao Z; Dixit R; Herbst R; Tice DA
Oncotarget; 2018 May; 9(33):22960-22975. PubMed ID: 29796165
[TBL] [Abstract][Full Text] [Related]
10. GDNF promotes hair formation and cutaneous wound healing by targeting bulge stem cells.
Lisse TS; Sharma M; Vishlaghi N; Pullagura SR; Braun RE
NPJ Regen Med; 2020; 5():13. PubMed ID: 32566252
[TBL] [Abstract][Full Text] [Related]
11. RET overexpression leads to increased brain metastatic competency in luminal breast cancer.
Jagust P; Powell AM; Ola M; Watson L; de Pablos-Aragoneses A; García-Gómez P; Fallon R; Bane F; Heiland M; Morris G; Cavanagh B; McGrath J; Ottaviani D; Hegarty A; Cocchiglia S; Sweeney KJ; MacNally S; Brett FM; Cryan J; Beausang A; Morris P; Valiente M; Hill ADK; Varešlija D; Young LS
J Natl Cancer Inst; 2024 Jun; ():. PubMed ID: 38852945
[TBL] [Abstract][Full Text] [Related]
12. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression.
Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL
Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131
[TBL] [Abstract][Full Text] [Related]
13. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
[TBL] [Abstract][Full Text] [Related]
14. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer.
Lin WD; Fan TC; Hung JT; Yeo HL; Wang SH; Kuo CW; Khoo KH; Pai LM; Yu J; Yu AL
Cancer Immunol Res; 2021 Jan; 9(1):113-122. PubMed ID: 33177111
[TBL] [Abstract][Full Text] [Related]
15. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
Pietrobono S; Anichini G; Sala C; Manetti F; Almada LL; Pepe S; Carr RM; Paradise BD; Sarkaria JN; Davila JI; Tofani L; Battisti I; Arrigoni G; Ying L; Zhang C; Li H; Meves A; Fernandez-Zapico ME; Stecca B
Nat Commun; 2020 Nov; 11(1):5865. PubMed ID: 33203881
[TBL] [Abstract][Full Text] [Related]
16. Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation.
Zhang N; Lin S; Cui W; Newman PJ
Blood Adv; 2022 Jul; 6(13):3945-3955. PubMed ID: 35507766
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases.
Xie X; Kong S; Cao W
Front Immunol; 2023; 14():1168023. PubMed ID: 37256139
[TBL] [Abstract][Full Text] [Related]
18. Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers.
Fang H; Li H; Zhang H; Wang S; Xu S; Chang L; Yang Y; Cui R
Front Pharmacol; 2022; 13():1019312. PubMed ID: 36313354
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion.
Li J; Long Y; Sun J; Wu J; He X; Wang S; Wang X; Miao X; Huang R; Yan J
Front Cell Dev Biol; 2022; 10():931132. PubMed ID: 36092699
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Sialylation in Cancer: Therapeutic Opportunities.
Munkley J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
